The phorbol ester phorbol 12-myristate 13-acetate induces remarkable phenotypic changes in intestinal HT-29 M6 cells; these changes consist of loss of homotypic adhesion and inactivation of E-cadherin. In parallel, cell growth is retarded. We have transfected HT-29 M6 cells with an activated form of the conventional protein kinase C alpha (cPK-C alpha). Expression of this isoform induced the acquisition of a scattered phenotype, similar to that adopted by cells after addition of phorbol 12-myristate 13-acetate, with very low cell-to-cell aggregation and undetectable levels of functional E-cadherin. These cell clones were highly motile and rapidly invaded embryonic chick heart fragments. Furthermore, cells expressing activated-cPK-C alpha showed decreased proliferation in comparison to control clones. We have also studied how these two apparently antagonistic changes affect the tumorigenic ability of HT-29 M6 cells. When the different cell clones were xenografted into athymic mice, the effect on cell growth seemed to predominate. Expression of activated-cPK-C alpha significantly reduced the size of the tumors; the cells with the highest level of expression did not even form subcutaneous tumors. Besides their smaller size, the morphology of these tumors was clearly different from those originated by HT-29 Mg cells, and they could be defined as infiltrative on anatomo-pathological basis. These results indicate that cPK-C alpha controls both cell-to-cell adhesion and proliferation of intestinal cells.
机构:
Univ Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USA
Bakajsova, D
Clifton, GL
论文数: 0引用数: 0
h-index: 0
机构:
Univ Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USAUniv Arkansas Med Sci, Dept Pharmaceut Sci, Coll Pharm, Little Rock, AR 72205 USA
机构:
Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USAEli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Lahn, M
Sundell, K
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Sundell, K
Gleave, M
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Gleave, M
Ladan, F
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Ladan, F
Su, C
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Su, C
Li, S
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Li, S
Ma, D
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Ma, D
Paterson, BM
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA
Paterson, BM
Bumol, TF
论文数: 0引用数: 0
h-index: 0
机构:Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Div Oncol Prod Dev, Indianapolis, IN 46285 USA